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N-CHLORO-N-METHYL GLUCAMINE AND
N-CHLORO-N-NIETHYL GLUCAMINE
ESTERS AS NOVEL SAFE AGENTS FOR
WATER DISINFECTION
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BACKGROUND OF THE INVENTION
1. Field of the Invention

The present invention relates to N-chloro-N-methyl glu
camine and N-chloro-N-methyl glucamine esters. and their

10

use as agents for water disinfection and as mild oxidizing

agents for the radiolabeling of oxidation-sensitive organic
molecules.

2. Description of the Related Art

procedures involving oxidation-sensitive organic molecules

Chloramines are widely known as useful water disinfect

and similar substrates. The present inventors have observed
that the N-chloro derivatives of secondary amines. such as
N-methyl glucamine and its esters. are much weaker oxi
dizing agents than N-chloro compounds. such as
chlorarnine-T and halazone. When used in radiohalogena
tion procedures. N~chloro secondary amines do not oxidize
most organic molecules.

ing agents. Among the most popular chlorarnine water
disinfecting agents is halazone (p-N.N
dichlorosulfamylbenzoic acid). While effective. halazone
sutfers from some important disadvantages. including its
strong. unpleasant chlorine odor. its sensitivity to light. its
relatively low solubility in water. and. perhaps most
importantly. the formation of potentially carcinogenic chlo

With the foregoing and other objects. advantages and

n'nated hydrocarbons which are generated as the result

reaction with impurities commonly found in water supplies.
In view of these disadvantages. it should be apparent that

wherein R is —H or —COR2. wherein R2 is lower alkyl.
These compounds are useful as disinfecting agents. particu
larly for disinfecting water supplies. When used as a
disinfectant. the compounds of the present invention gener
ate N-methyl glucamine. a very safe agent. in parts per
millions.
A further object of the present invention is to meet the
need for a mild oxidizing agent for use in radiohalogenation

25

features of the invention that will become hereinafter
apparent. the nature of the invention may be more clearly

understood by reference to the following detailed descrip

there still exists a need in the art for improved water

tion of the preferred embodiments of the invention and to the

disinfecting agents.

appended claims.

Chloramines. in particular chlorarnine-T (CAT) are fre

BRIEF DESCRIPTION OF THE DRAWINGS

quently used in the radiolabeling of organic molecules by

FIG. 1: UV absorbance spectra of NaOCl (1). penta-O

halogenation. for example. as described in U.S. Pat. No.
5.424.402 (“the ’402 patent”). the contents of which are

acetyI-N-chloro-N-methylglucamine (NCMG)(2). and

incorporated herein by reference. According to the method

penta-O-acetyl-N-methylglucamine (NMG)(3).

of the ’402 patent an organic molecule may be radiolabeled

by reaction with 12512. Normally. the 12512 is released from

FIG. 2: Fraction of L-tyrosine ('I‘yr). mono-3-iodo-L
35

tyrosine (Iodo-Tyr). and 3.5-diiodo-L-tyrosine (Diiodo-Tyr)

its sodium salt by oxidation with chloramine-T. The disad
vantage of this procedure is that residual CAT in the reaction
mixture frequently causes oxidative decomposition of the

for four methods of iodinating L-tyrosine in phosphate

organic molecule rendering the procedure useless. There

iodoleucine enkephalin Iodo-Leu-Lek). and diiodoleucine
enkephalin (Diiodo-Leu-Enk) for six methods of iodinated
leucine enkephalin in phosphate buffer.
FIG. 4: Susceptibility of L pneumophila AAlOO to dif

buffer (0.01M. pH 7.2).
FIG. 3: Peak areas of leucine enkephalin (Leu-Enk).

exists a need for a mild oxidizing agent that is capable of

releasing molecular halogens from their salts without oxi
dizing organic molecules to be labeled.
N-methyl glucarnine is known in the prior art as a
solubilizing agent in the formulation of intravenous

pharmaceuticals. enabling high concentrations of pharma

45

ceuticals to be administered. However. prior to the present

FIG. 6: Susceptibility of L pneumophila AAlOO in

invention the particular substituted glucarnines of the
present invention. and their use in the puri?cation of water.
was not known.

co-culture with H. vermifonm's to 105 ppm NCMGE in 30
minutes incubation.
50

SUMMARY OF THE INVENTION

Accordingly. a major object of the present invention is to
meet the art-recognized need for a safe. e?ective and inex 55

pensive method for disinfection of water supplies.
Advantageously. the compounds of the present invention
minimize the formation of the carcinogenic chlorinated
hydrocarbons which are currently generated as the result of
disinfection with halazone and similar agents. Furthermore.
these compounds satisfy the need for an agent that can be
conveniently used in households to disinfect water. espe
cially in developing nations. as a replacement for Halazone.
The present inventors have found that chlorination of

N-methyl glucamine yields N-chloro-N-methyl glucamine.
a powerful germicidal agent. The compounds of the present
invention have the following structure:

ferent NCMGE concentrations.
FIG. 5: Kinetics of lu'lling of L. pneumophila by 105 ppm
NCMGE.

FIG. 7. Kinetics of multiplication of L. pneumophila
AAlOO within H. vemufomtis.
DETAILED DESCRIPTION OF THE
PREFERRED EMBODIMENTS OF THE
INVENTION
The present inventors have found that chlorination of

N-methyl glucamine yields N-chloro-N-methyl glucarnine.
a powerful germicidal agent. The compounds of the present
invention comprise the following structure:

65

wherein R is --H or —COR2. wherein R2 is lower alkyl.
These compounds are useful as disinfecting agents. particu

5,753.70]
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larly for disinfecting water supplies. When used as a
disinfectant. the compounds of the present invention gener
ate N-methyl glucarnine. a very safe agent. in parts per
millions.
The compounds of the present invention are also useful as
mild oxidizing agents for use in radiohalogenation proce

embodiment. the method of the present invention provides
that the compound according to the present invention and
the radiolabeled halide salt are mixed together ?rst. such that
the radiolabeled halide salt is converted into molecular

radiolabeled halogen; then. the organic compound to be
labeled is added to the mixture.

dures involving oxidation-sensitive organic molecules. in
particular oxidation-sensitive biomolecules and similar sub
strates. The present inventors have observed that the
N-chloro derivatives of secondary amines. such as N-methyl
glucamine and its esters. are much weaker oxidizing agents
than N-chloro compounds. such as chlorarnine-T and hala
zone. When used in radiohalogenation procedures. N-chloro
secondary amines do not oxidize most biomolecules.
The compounds of the present invention may be synthe
sized by any means known to the skilled artisan. Preferably.
the compounds of the present invention are prepared from
N-methylglucamine. which may be obtained commercially
or may be synthesized according to any method known to
the skilled artisan. For example. N-methylglucamine may be

For use in the present invention. the radiolabeled halogen
salt is preferably selected from the group consisting of

sodium. potassium. lithium. rubidium. cesium. magnesium.
calcium. and ammonium salts. Particularly preferred are
sodium halogen salts. most preferably sodium iodide.
The following examples are presented in order to more

fully illustrate the preferred embodiments of the invention.
They should in no way be construed. however. as limiting
the broad scope of the invention.

syndresizes from D-glucose and methylamine according to
the method of Karrer (Helv. Chim. Acta 20:83 (1937). the
contents of which are incorporated herein by reference).
The present invention also provides compositions of

EXAMPLE 1

matter comprising one or more of the compounds of the

present invention and a suitable carrier therefor. These 25

compositions may also include other disinfectant

compounds. including chlorinaling compounds such as

Preparation of Penta-O-Acetyl-N-Chloro-N

halazone. or other antibiotic agents. Compositions according
to the present invention may be formulated in any manner
suitable for use as a disinfectant. For example. compositions

Methylglucamine (NCMGE)
30

of the present invention may be provided as aqueous solu

tions or suspensions. More preferably. the compositions of
the present invention are provided in solid form. Particularly
preferred are tablet and granular forms of the composition of
the present invention. which provide for easy storage and
handling. Tablets and granules may be formulated according

a. Synthesis of Penta-O-Acetyl-N-Methylglucamine

(NMGE)
35

Penta-O-Acetyl-N-Methylglucamine Perchlorate

to any means known in the art. For the purposes of the

present invention tablets may be of any convenient size;
granules are small grains of the composition of the present
invention; preferably. said grains are between two and forn
millimeters in diameter.
The present invention also provides a method of disin

fecting water comprising adding the compounds or compo
sitions of the present invention in an amount su?icient to
disinfect the water. For the purposes of the present

45

invention. disinfection encompasses killing bacteria and
protozoans living in the water to be disinfected. Preferably.
the compounds or compositions of the present invention will
be added to the water to be disinfected such that the ?nal

ll
drno-o-c-cmn

concentration of the compounds of the present invention in
the water will be at least 10 parts per million (ppm). more

preferably from 60-200 ppm. most preferably 105 ppm.
The present invention also provides a method for non

destructively radiolabeling biomolecules by halogenation.
The method of the present invention is advantageously

N-methylglucamind 10 g) was dissolved in 7.4 g (4.4 ml)
55

applied to radiolabeling of oxidation-sensitive organic
molecules. particularly oxidation-sensitive biomolecules.
The method of the present invention comprises
(a) reacting a compound according to the present inven

acetate (500 ml) was added. The solution was stirred. and 73
g of acetyl chloride was added dropwise. The solution was
left stirring at room temperature for four days until a white
solid was formed. The resulting white solid was ?ltered and

tion with a radiolabeled halide salt and an organic
molecule which is desired to be radiolabeled such that

washed with ether and recrystallized from acetone/
petroleum ether mixture and dried overnight in a vacuum
oven. The melting point of the solid was l48°-150° C.; MW

said radiolabeled halogen reacts directly with said
organic molecule to produce a radiohalogenated

organic molecule; and
(b) recovering said radiohalogenated organic molecule.
The method of the present invention may advantageously be
carried out in the presence of a bu?er. In a preferred

of (70%) perchloric acid in a round bottom ?ask. Ethyl

65

504.45; 1l-l-NMR (DMSO-dG) (FIG. 1): 8 2.05 (15H. m.
protons a). 2.56 (3H. S. protons b). 3.13 (2H. m. protons c).
4.20 (2H. m. protons d). 4.98 (1H. proton e). 5.05 (1H. m.
proton f. 5.27 (2H. protons g). 8.47 (2H. broad s. protons h).

5.753.701
6
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b. Synthesis of Penta-O-Acetyl-N-Chloro-N

minutes at 25° C.. and a 10.0 ml aliquot was mixed with an

Methylglucamine (NCMGE)

equal volume of l-aminocyclohexanecarboxylic acid
(0.02M). (t=0). The mixture was stored at 25° C. and

assayed periodically by titration. as described above. A

Pcnta-O-Acetyl-N~Chloro<N-Methylglucamine

i”
III-C1
cnzc

I

control experiment was conducted in the absence of the
amino acid.

2. Iodination of L-tyrosine
Solutions
Phosphate buffer (0.01M. pH 7.4): A total of 5.0 g of
NaCl. 0.1 g KCl. 0.57 g Na2HPO4. and 0.1 g KH2PO4 were

0

II

o w-c-o-c-crna

dissolved in 500 ml of glass distilled water. The pH of the
solution was adjusted to 7.4 with either NaOH or HCl. as
needed.
L-tyrosine solun'on: A total of 25 mg of L-tyrosine was

dissolved in 100 ml of phosphate buffer.
Sodium Iodide solution: A total of 207 mg of sodium
iodide was dissolved in 100 ml phosphate bu?er.

Penta-O-acetyl-N-chloro-N-methylglucamine solution
(NCMGE): A total of 141 mg of NCMGE was dissolved in

100 ml of phosphate bulfer (0.01M. pH 7.4).

Experimental

Penta-O-acetyl-N-methylglucamine (3.0 g) was dissolved
in water and the pH of the solution was adjusted 6.0 by

The HPLC system for analysis was as follows:

addition of 2N NaOH solution. Chlorine gas was bubbled

Mobile phase=Distilled waterlmethanol/85% phosphoric

into the solution for a few minutes until a white solid was
formed. The solid was ?ltered and washed with water and
dried in a vacuum oven. The melting point was 77°-79° C.; 25

Flow rate=l.0 mllmin.
Detector UV wavelength 254 nm

MW 439.45; ‘H-NMR (coca): 6 2.08 (15H. m. protons at).
2.93 (3H. S. protons b). 3.05 (2H. m. protons c). 4.20 (2H.
m. protons d). 5. 10 (IR. proton e). 5.40 (IH. m. proton f).
5.44 (2H. protons g).
Elemental analysis: Found: C.46.24; H. 5.9 1; N. 3.17; Cl.

Temperature=ambient.
Method 1: A total of 0.2 ml of L-tyrosine solution. 0.02 ml
sodium iodide solution. and 0.108 ml of phosphate buffer
were mixed in a tube for two minutes. then 0.172 ml of
30

8.15%.

Calculated for CnHmOmNCl: C. 46.41; H. 5.9 l; N.
3.18; Cl. 8.08%.
The product was also identi?ed by UV spectrophotometry

(FIG. 1).

acid=(550/450/8).

35

EXAMPLE 2

NCMGE solution was added (t=0). and 50 pl samples were
withdrawn at 2 and 15 minutes and injected directly into the
HPLC.
Method II: A total of 0.2 ml of L-tyrosine solution. and
0.02 ml of sodium iodide solution were mixed in a tube for
2 minutes. then 0.780 ml of NCMGE solution was added.
and 50 pl samples were withdrawn at 2 and 15 minutes and

injected directly into the HPLC.
3. Iodination of leucine enkephalin
Solutions

The Use of NCMGE in Radiolabeling Techniques
1. Chemical Stability of a Model Amino Acid

Phosphate butler (0.01M. pH 7.4). sodium iodide

(l-Aminocyclo-hexane Carboxylic Acid) in the Presence of
Chloramine-T. NCMG. and NCMGE

solution. and NCMGE solution were the same as those for

nation of the amine group. are very unstable (Hussain et al.

the iodination of tyrosine.
Leucine enkephalin solution: Atotal of 8.9 mg of leucine
enkephalin was dissolved in 10 ml of phosphate buffer

1995 Analyt. Biochem 2242221-226; Awad et a1. 1990 J.
Pharm Sci. 79:1121-1122; the contents of both of these

(0.01M. pH 7.4).
Experimental

N-chloro amino acids. such as N-chloro-l-amino

cyclohexane carboxylic acid. which are formed by chlori

The HPLC system for analysis was described above

articles are incorporated herein by reference). Their decom
positions are associated with loss of chlorine titer. In order
to determine whether NCMG and NCMGE chlorinate

l-aminocyclohexanecarboxylic acid. iodometric titration

(Section 2). The conditions were the same as those described
50

the detector UV wavelength was set at 270 nm.

was used to follow the reaction.
A solution of l-aminocyclohexanecarboxylic acid con

taining 2><l0_3M was prepared in 0.1M phosphate buffer
(pH 7.0) and equilibrated for 2 minutes at 25° C. For the
Chloramine-T (CAT) experiments. a solution of CAT (1X10‘
3M) in water was freshly prepared and equilibrated for 2

above for the analysis of iodinated tyrosine products. except
the mobile phase was (0.1M NaH2PO4/Methanol=1/ 1) and
Method 1: A total of 0.2 ml of leucine enkephalin. 0.020
ml sodium iodide solution. and 0.083 ml of phosphate butfer

55

were mixed in a tube for 2 minutes. then 0.172 ml of
NCMGE solution was added (t=0). At the end of the reaction

(2 and 15 minutes). 25 pl of 20% sodium thiosulfate solution
was added and 50 pl samples were withdrawn and injected
directly into the HPLC. The addition of sodium thiosulfate
was found necessary to decompose the residual NCMGE

minutes at 25° C. Equal volumes (10.0 ml) of the two
solutions were mixed (t=0) and stored at 25° C. Aliquots of

the mixture (4.0 ml) were assayed periodically using stan

dard iodometric titration; i.e. addition of excess KI and back 60 because NCMGE interfered with the enkephalin peaks in the

titration of the liberated iodine with sodium thiosulfate using

HPLC.
Method 11: A total of 0.2 ml of leucine enkephalin and

starch as an indicator. A control experiment was carried out

by following the chlorine titer of a solution of CAT in

of either NCMG or NCMGE (1x10_3M) in phosphate butler

0.020 ml sodium iodide were mixed in a tube for 2 minutes
and NCMGE solution (0.755 ml) was added (t=0). At the
end of the reaction (2 and 15 minutes), 25 pl of 20% sodium
thiosulfate solution was added and 50 ul samples were

(0.1M. pH 7.0) was freshly prepared and equilibrated for 2

withdrawn and injected directly into the HPLC.

phosphate buffer in the absence of the amino acid.
For the experiments with NCMG and NCMGE. a solution

65
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4. Iodination of L-tyrosine
To determine whether NCMGE would have practical
activity in the radiohalogenation of amino acid. L-tyrosine.

B. Coincubation of Hartimannella vermiformis and

Legionella pneumophila
Amoebae H. vermiformis were suspended in assay
medium to give a ?nal concentration of 105 cell per ml.
Tissue culture ?asks containing amoebae were inoculated

was selected as a model and compared with the method

employed by Hussain et. al (1995 Analyr. Biochem

with Legionella pneumophila, suspended in Pucks’ saline to

224 :22 l-226). the contents of which are incorporated herein
by reference. The results in FIG. 2 show that when NCMGE
was used. the yield of the two iodinated species of
L-tyrosine were signi?cantly greater with both 2 and 15
minutes incubation times than those obtained with CAT and
iodobead and close to that of N-chloromorpholine.

give a ?nal concentration of 103 bacteria per ml. and
incubated at 37° C. 1.2 ml aliquots were withdrawn imme

diately and 1. 2. 3. 5. and 7 days after inoculation. Ofthe 1.2
ml. 0.2 ml was cultured on BCYE agar plates in order to

follow the increase in the number of bacteria The remaining
1.0 ml was centrifuged at 8000 rpm for 5 minutes. The
bacterial pellet was washed twice with sterile deionized
water. The pellet was then suspended in 1.0 ml 105 ppm
NCMGE solution for 30 minutes. After 30 minutes. two 20
pl aliquots of this NCMGE solution were diluted in 0.01M
phosphate buffer to an approximate bacterial concentration
of 103 and 102/100 pl. 100 p1 of these two dilutions were
deposited on BCYE agar plates and incubated at 37° C. for

5. lodination of leucine enkephalin
To determine whether NCMGE would have practical
utility in radiohalogenation of small peptide. leucine
enkephalin was selected as a model substrate for comparison

of iodination procedures employing CAT solution and
NCMGE. The methods were tested using 2 and 15 minute
incubation times. The results in FIG. 3 show that when
NCMGE was used. the yield of the two iodinated leucine

enkephalin species were signi?cantly greater with both 2

20

with a 15 minutes incubation time. the yield of the apparent
diiodinated species (labeled diiodo leu-enk in FIG. 3) was
signi?cantly smaller than when NCMGE was present. This
appears to be the result of decomposition of leucine
enkephalin. as indicated by the smaller amount of all species
following 15 minutes exposure to CAT alone (see FIG. 3).

The antimicrobial activity of N-chloramine penta-O—
acetyl-N-chloro-N-methylglucarnine (NCMGE) was exam
25

ined against Legionella pneumophila ?rst using the mini

30

mum inhibitory concentration (MIC) method. This method
is based on incubation of the organism for 30 minutes at
different NCMGE concentrations. The results shown in FIG.
4 indicate that the MIC for NCMGE is 105 ppm. Second the
antimicrobial activity was examined using the contact ger

EXAMPLE 3

The germicidal activity of Penta-O-acetyl-N-chloro

micidal e?iciency (CGE). This method involves examining
the bactericidal activity of NCMGE (105 ppm) at different
incubation times. After each time interval. the chlorine
activity of NCMGE was quenched by 0.01M sodium

N-methylglucamine (NCMGE)
The antimicrobial activity of NCMGE was examined in

the following experiments:
A. Legionella pneumophila

35

Legionella pneumophila strain AAlOO was inoculated

into buffered charcoal-yeast extract (BCYE) agar plates and
incubated for 48 hours at 37° C. The bacteria were sus

density of 0.7-0.8 at 550 um.
15 pl of bacterial suspension was mixed with 7.0 ml

compared to a control of 1000 cfu and incubation time of 30
minutes. The results shown in Table [I show that this
NCMGE concentration kills all the strains of Legionella to
which it was exposed.

0.01M phosphate buffer (pH 7.4) containing disinfectant
compounds as listed in Table I. The concentration of bacteria

Susceptibility of L pneumophila serogroups to 105 ppm NCMGE
compared to a control of 10(1) cfu and incubation time of 30 minutes

Serogroup

Names and concentrations of N-chloro compounds

50

used in germicidal claw‘em.

Control

Monochloramine (NHZCI)
Penta-O-aoetyl-N-chloro-N-methylglmamine
Penta-O-acetyl-N-chloro-N-methylglucamine
Pema-O-acetyl-N-chloro-N-methylglucamine

TABLE 11

45

TABLE 1

Compound

bisul?te. The results in FIG. 5 indicate that the shortest time
for which growth of L. pneumophila is not observed was
found to be 20 minutes.

The antimicrobial activity of NCMGE (105 ppm) was
also examined against a serogroups of L. pneumophila

pended into 0.01M phosphate bu?er pH 7.4 to an optical

in this suspension was approximately 1 million bacteria/ml.
After 30 minutes the activity of the disinfectant compounds
was quenched with 0.4 ml 0.01M sodium bisul?te.

three days. At the end of the three day period. the colony
forming units were enumerated.
Results

and 15 minutes incubation times. When CAT was used alone

0

three day incubation paiod. the colony forming unit was
enumerated. Another experiment was conducted against the
serogroups of legionella pneumophila using NCMGE in a
concentration of 105 ppm.

WNHOQM-bIt: 0
Dallas 1

l0
30
60
105

two ?nal dilutions were grown on BCYE agar plates that
were incubated at 37° C. for three days. At the end of the

% Survival

Philadelphia 1
Togus 1
Bloomington 2
Los Angeles 1

Concentration

Two aliquots of 20 pl of the ?nal solution of each of the
above was diluted in 0.01M phosphate butfer to approximate
bacterial concentrations of 103 and 102/100 pl . 100 pl of the

Strain

Chicago 2

Chicago 8

I-lMb?

Concord 3
IN 23
Leiden l
797-PA-H
570-Co-l-I
82A3l05

‘The serogroups of L pneumophila are distinguished by their lipopolysac

charide antigen

Finally. the antimicrobial activity of NCMGE (105 ppm)
was tested against a coculture of Legionella pneumophila

and H. vermij‘ormis in which the L.pneum0phila typically
become more resistant to chlorine. The results shown that

5,753,701
9

10

NCMGE (105 ppm) killed 95% of the bacteria at day 4 (FIG.
6). the time at which L. pneumophila typically reach their
maximum growth (as shown in FIG. 7). The results in FIG.

7. The composition of claim 6. wherein said solid com

6 also demonstrate that NCMGE has a powerful sustained

position is formulated as granules.
8. The composition of claim 6. wherein said composition

antimicrobial activity.

is formulated as tablets.

While the invention has been described and illustrated

9. The composition of claim 5. wherein said composition

herein by references to various speci?c material. procedures

is formulated as an aqueous solution of one or more com

and examples. it is understood that the invention is not
restricted to the particular material, combinations of
material. and procedures selected for that purpose. Numer
ous variations of such details can be implied and will be

pounds according to claim 1.
10. A method of disinfecting water comprising adding to
10

appreciated by those skilled in the art.
What is claimed is:

1. A substituted N-chloro-N-methyl glucamine compound
comprising the following structure:

water to be disinfected one or more compounds according to
claim 1 in an amount su?icient to kill bacteria and proto
zoans in the water.

11. The method of claim 10. wherein the compound or
compounds are added in an amount su?icient to kill all the

wherein R is —H or —COR2. wherein R2 is lower alkyl.
2. The compound of claim 1. wherein R2 is methyl.
3. The compound of claim 1. wherein R2 is ethyl.
4. The compound of claim 1. wherein said compound is

penta-O-acetyl-N-chloro-N-methylglucamine.

5. A composition of matter comprising one or more

compounds according to claim 1. and a carrier therefor.

6. The composition of claim 5. wherein said composition
is formulated as a solid.
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bacteria and protozoans in the water.
12. The method of claim 10. wherein the ?nal concentra
tion of the compounds of the present invention in the water
is at least 10 parts per million (ppm).
13. The method of claim 10. wherein the ?nal concentra
tion of the compounds of the present invention in the water
is from 60-200 ppm.
14. The method of claim 10. wherein the ?nal concentra
tion of the compounds of the present invention in the water
is 105 ppm.

